glatiramer acetate

FDA Drug Profile — Glatiramer Acetate, GLATIRAMER ACETATE

glatiramer acetate is listed in the FDA National Drug Code directory with 12 NDC codes, marketed under brand names including Glatiramer Acetate, GLATIRAMER ACETATE. Available dosage form: injection, solution.

Drug details

Generic Name
glatiramer acetate
Brand Names
Glatiramer Acetate, GLATIRAMER ACETATE
Application Number
ANDA091646
Sponsor
Mylan Pharmaceuticals Inc.
NDC Codes
12
Dosage Forms
INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Active Ingredients
GLATIRAMER ACETATE

Indications and Usage

1 INDICATIONS AND USAGE Glatiramer acetate injection is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. Glatiramer acetate injection is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults ( 1 ).

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.